exenatide and Eosinophilia

exenatide has been researched along with Eosinophilia* in 2 studies

Other Studies

2 other study(ies) available for exenatide and Eosinophilia

ArticleYear
Exenatide ER-induced eosinophilia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, 06-23, Volume: 77, Issue:13

    Topics: Delayed-Action Preparations; Diabetes Mellitus, Type 2; Eosinophilia; Exenatide; Female; Humans; Hypoglycemic Agents; Middle Aged

2020
Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site.
    The American Journal of dermatopathology, 2014, Volume: 36, Issue:6

    Sclerosing lipogranuloma is a granulomatous reaction to the injection of a high-viscosity fluid in the tissues for the cosmetic purpose of improving body contour; lesions on the extremities and buttocks are commonly the results of injections of therapeutic agents in oily vehicles. Exenatide, once-weekly injection, is a therapeutic method for patients with type 2 diabetes. Here, we describe a case of exenatide once weekly induced eosinophilic sclerosing lipogranuloma at the injection site of a 62-year-old patient. To the best of our knowledge, the histopathologic features of this adverse event have not been reported in the medical literature.

    Topics: Diabetes Mellitus, Type 2; Eosinophilia; Exenatide; Granuloma; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Male; Middle Aged; Panniculitis; Peptides; Skin Diseases; Venoms

2014